4.6 Article

A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study

Johannes Attems et al.

Summary: Several staging systems exist for the neuropathological diagnosis of LBD, with varying levels of inter-rater reliability. The LPC system, based on a dichotomous approach for scoring LP, showed good reproducibility and allowed for the classification of all cases into distinct categories. It may serve as a reliable and useful standard future approach for the post-mortem evaluation of LP.

ACTA NEUROPATHOLOGICA (2021)

Review Neurosciences

Reverse engineering Lewy bodies: how far have we come and how far can we go?

Mohamed Bilal Fares et al.

Summary: Lewy bodies (LBs) are important pathological features of Parkinson disease and other neurodegenerative diseases, with increasing evidence suggesting that the aggregation of alpha-synuclein plays a central role in LB formation. However, little is known about the mechanisms underlying LB formation, their biochemical and ultrastructural properties, evolution and spreading with disease progression, and their role in neurodegeneration.

NATURE REVIEWS NEUROSCIENCE (2021)

Article Neuroimaging

Altered structural connectivity networks in dementia with lewy bodies

Nicolas Nicastro et al.

Summary: This study found that DLB patients had decreased global efficiency, clustering, modularity, and small-worldness in structural networks compared to controls. Nodal measures also showed decreased clustering in bilateral temporal regions and decreased closeness centrality in extensive brain areas in DLB patients. Additionally, DLB patients exhibited disorganized modules, including default mode network and dorsal attentional network, compared to clearly identified modules in controls.

BRAIN IMAGING AND BEHAVIOR (2021)

Review Neurosciences

Rapid and Reversible Development of Axonal Varicosities: A New Form of Neural Plasticity

Chen Gu

Summary: Axonal varicosities are enlarged and heterogeneous structures that profoundly affect axonal function, believed to develop via slow accumulation of damage in various neurological disorders. Recent studies have shown that these varicosities can be rapidly induced by mechanical stress in vitro, with limited understanding of the regulatory mechanisms involved. This new form of neural plasticity may hold promise for developing strategies to reverse axonal injury in brain injuries and neurodegenerative diseases.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Review Medicine, General & Internal

Parkinson's disease

Bastiaan R. Bloem et al.

Summary: Parkinson's disease is a neurodegenerative condition with diverse causes and clinical presentations. Diagnosis is clinically based, and treatment goals vary from person to person, emphasizing the need for personalized management. Currently, there is no therapy to slow down or arrest the progression of Parkinson's disease.

LANCET (2021)

Review Neurosciences

Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson's Disease

Kathrin Doppler

Summary: Skin biopsies can serve as a potential diagnostic tool for Parkinson's disease and other synucleinopathies, with important implications for pre-mortem histopathological confirmation and clinical research targeting alpha-synuclein aggregates.

JOURNAL OF PARKINSONS DISEASE (2021)

Review Biochemistry & Molecular Biology

Proteolytic α-Synuclein Cleavage in Health and Disease

Alexandra Bluhm et al.

Summary: In Parkinson's disease, the aggregation of alpha-synuclein is a neuropathological hallmark, but the mechanisms behind this aggregation are not fully understood. Recent research suggests that oxidative stress induced by metal ions and post-translational modifications can affect the conformation of alpha-synuclein, influencing its propensity for aggregation and neurotoxicity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

Passive immunotherapy with a novel antibody against 3pE-modified A? demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice

Jonathan Janssens et al.

Summary: The imbalance between production and clearance of Aβ peptides is a crucial step in AD pathogenesis, making Aβ a promising therapeutic target. Research has shown that a high-affinity antibody targeting Aβ peptides with a pyroglutamate residue at amino acid position 3 can significantly reduce amyloid burden in mouse brains. Furthermore, combining this antibody treatment with chronic BACE1 inhibitor treatment leads to significant clearance of pre-existing amyloid deposits in the brain without inducing microhemorrhages or other histopathological findings.

NEUROBIOLOGY OF DISEASE (2021)

Review Biochemistry & Molecular Biology

Synucleinopathies: Where we are and where we need to go

Ines Caldeira Bras et al.

JOURNAL OF NEUROCHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro

Janett Koeppen et al.

MOLECULES (2020)

Review Biochemistry & Molecular Biology

The emerging role of ?-synuclein truncation in aggregation and disease

Zachary A. Sorrentino et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

The Role of α-Synuclein Oligomers in Parkinson's Disease

Xiao-yu Du et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Effects of alpha-synuclein post-translational modifications on metal binding

Nazareno Gonzalez et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Article Neurosciences

Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease

Chen Tian et al.

TRANSLATIONAL NEURODEGENERATION (2019)

Review Biochemistry & Molecular Biology

Spreading of alpha-synuclein - relevant or epiphenomenon?

Bryan A. Killinger et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Editorial Material Clinical Neurology

Alpha-synuclein: prion or prion-like?

Rehana K. Leak et al.

ACTA NEUROPATHOLOGICA (2019)

Editorial Material Clinical Neurology

Calling α-synuclein a prion is scientifically justifiable

Joel C. Watts

ACTA NEUROPATHOLOGICA (2019)

Article Clinical Neurology

Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging

Charles H. Adler et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)

Article Multidisciplinary Sciences

Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein

Katsuya Araki et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Clinical Neurology

alpha-Synuclein in blood cells differentiates Parkinson's disease from healthy controls

Suaad Abd Elhadi et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Clinical Neurology

alpha-Synuclein in blood cells differentiates Parkinson' disease from healthy controls

Suaad Abd Elhadi et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Review Clinical Neurology

Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies

Kurt A. Jellinger

JOURNAL OF NEURAL TRANSMISSION (2018)

Article Medicine, Research & Experimental

Cell Biology and Pathophysiology of α-Synuclein

Jacqueline Burre et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Article Biology

Cryo-EM structure of alpha-synuclein fibrils

Ricardo Guerrero-Ferreira et al.

Article Multidisciplinary Sciences

Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel

Binsen Li et al.

NATURE COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

Structural and functional analyses of pyroglutamate-amyloid--specific antibodies as a basis for Alzheimer immunotherapy

Anke Piechotta et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Article Pharmacology & Pharmacy

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy

Torsten Hoffmann et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)

Review Clinical Neurology

Alpha-synuclein oligomers: a new hope

Nora Bengoa-Vergniory et al.

ACTA NEUROPATHOLOGICA (2017)

Article Biochemistry & Molecular Biology

Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization

Filsy Samuel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Cellular response of human neuroblastoma cells to α-synuclein fibrils, the main constituent of Lewy bodies

Laura Pieri et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)

Review Neurosciences

New insights into cellular α-synuclein homeostasis in health and disease

Ulf Dettmer et al.

CURRENT OPINION IN NEUROBIOLOGY (2016)

Article Neurosciences

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease

Nour K. Majbour et al.

MOLECULAR NEURODEGENERATION (2016)

Article Multidisciplinary Sciences

Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading

Marija Iljina et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Geriatrics & Gerontology

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease

Ioannis U. Isaias et al.

FRONTIERS IN AGING NEUROSCIENCE (2016)

Review Neurosciences

Retrograde Axonal Degeneration in Parkinson Disease

Patricia Tagliaferro et al.

JOURNAL OF PARKINSONS DISEASE (2016)

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Article Geriatrics & Gerontology

An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice

Jeffrey L. Frost et al.

NEUROBIOLOGY OF AGING (2015)

Article Developmental Biology

Mouse strain and brain region-specific expression of the glutaminyl cyclases QC and isoQC

Corinna Hoefling et al.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2014)

Article Multidisciplinary Sciences

Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour

Giuliana Fusco et al.

NATURE COMMUNICATIONS (2014)

Review Neurosciences

The many faces of alpha-synuclein: from structure and toxicity to therapeutic target

Hilal A. Lashuel et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Article Multidisciplinary Sciences

Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β

Justin M. Nussbaum et al.

NATURE (2012)

Review Clinical Neurology

A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (Line 61) Mice

Marie-Francoise Chesselet et al.

NEUROTHERAPEUTICS (2012)

Review Clinical Neurology

Neuropathology underlying clinical variability in patients with synucleinopathies

Glenda M. Halliday et al.

ACTA NEUROPATHOLOGICA (2011)

Article Multidisciplinary Sciences

In vivo demonstration that α-synuclein oligomers are toxic

Beate Winner et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

Glutaminyl Cyclases Display Significant Catalytic Proficiency for Glutamyl Substrates

Franziska Seifert et al.

BIOCHEMISTRY (2009)

Article Behavioral Sciences

Parkinson's disease: The syndrome, the pathogenesis and pathophysiology

Anna L. Bartels et al.

CORTEX (2009)

Article Developmental Biology

Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain

Maike Hartlage-Ruebsamen et al.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2009)

Review Clinical Neurology

Pathophysiology of parkinsonism

Adriana Galvan et al.

CLINICAL NEUROPHYSIOLOGY (2008)

Article Neurosciences

Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered

Heiko Braak et al.

EXPERIMENTAL NEUROLOGY (2008)

Article Biochemistry & Molecular Biology

Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology

Stephan Schilling et al.

NATURE MEDICINE (2008)

Article Biochemistry & Molecular Biology

Calpain-resistant fragment(s) of α-synuclein regulates the synuclein-cleaving activity of 20S proteasome

Hyun Jin Kim et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)

Article Biochemistry & Molecular Biology

Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases

JY Sung et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

The aggregation kinetics of Alzheimer's β-amyloid peptide is controlled by stochastic nucleation

P Hortschansky et al.

PROTEIN SCIENCE (2005)

Article Multidisciplinary Sciences

Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations

WX Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemistry & Molecular Biology

Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions

S Schilling et al.

FEBS LETTERS (2004)

Review Biochemistry & Molecular Biology

α-synuclein and Parkinson's Disease

A Recchia et al.

FASEB JOURNAL (2004)

Article Biochemistry & Molecular Biology

Role of α-synuclein carboxy-terminus on fibril formation in vitro

IVJ Murray et al.

BIOCHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Substrate specificity of glutaminyl cyclases from plants and animals

S Schilling et al.

BIOLOGICAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

The P1′ specificity of tobacco etch virus protease

RB Kapust et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)

Article Biochemical Research Methods

Continuous spectrometric assays for glutaminyl cyclase activity

S Schilling et al.

ANALYTICAL BIOCHEMISTRY (2002)

Article Cell Biology

α-Synuclein is phosphorylated in synucleinopathy lesions

H Fujiwara et al.

NATURE CELL BIOLOGY (2002)

Article Biochemistry & Molecular Biology

A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly

BI Giasson et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)